Results 121 to 130 of about 26,501 (228)

Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization [PDF]

open access: yesGastroenterology, 2017
Lance L, Stein   +2 more
openaire   +2 more sources

Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis [PDF]

open access: yes
Jiayun Jiang,1 Hui Zhang,1 Jiejuan Lai,1 Shiyu Zhang,1 Yanjiao Ou,1 Yu Fu,2,* Leida Zhang1,* 1Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, People’s Republic of ...
Jiang J   +6 more
core  

Treatment of Liver Tumors with Transarterial Chemoembolization [PDF]

open access: yesSeminars in Interventional Radiology, 2018
Natalie, Poliektov, D Thor, Johnson
openaire   +2 more sources

Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma

open access: yes, 2011
Purpose: To compare short- and long-term clinical outcomes after conventional transarterial chemoembolization and drug-eluting bead (DEB) transarterial chemoembolization in hepatocellular carcinoma (HCC). Materials and Methods: Patients with unresectable
Bertini M   +16 more
core   +1 more source

DEBvscTACE_supplement_20190516_clean – Supplemental material for Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients

open access: yes, 2019
Supplemental material, DEBvscTACE_supplement_20190516_clean for Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients by In
Jung-Hwan Yoon (313986)   +10 more
core   +1 more source

Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment

open access: yesWorld Journal of Gastrointestinal Oncology
BACKGROUND Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Transarterial chemoembolization (TACE) combined with percutaneous radiofrequency ablation (RFA) has emerged as a promising treatment strategy for patients with unresectable HCC.
Fei, Jing   +4 more
openaire   +2 more sources

A Frameshift Mutation of the Pro-Apoptotic VDAC1 Gene in Cancers with Microsatellite Instability

open access: yesGut and Liver, 2011
Metastasis of hepatocellular carcinoma (HCC) to the ovary is notably rare. We present a case of HCC metastasis to the ovary with a review of the literature, which includes only 7 reported cases. A 43-year-old hepatitis B virus carrier was admitted with a
doaj   +1 more source

Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis

open access: yes, 2015
Xin Tian,1 Ying Dai,1 Da-qing Wang,2 Li Zhang,1 Cheng-guang Sui,1 Fan-dong Meng,1 Shen-yi Jiang,1 Yun-peng Liu,1 You-hong Jiang1 1Molecular Oncology Laboratory of Cancer Research Institute, The First Affiliated Hospital of China Medical ...
Meng F   +8 more
core  

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis

open access: yes, 2018
Wei-Fu Lv, Kai-Cai Liu, Dong Lu, Chun-Ze Zhou, De-Lei Cheng, Jing-Kun Xiao, Xing-Ming Zhang, Zheng-Feng Zhang Department of Interventional Radiology, Anhui Provincial Hospital, The First Affiliated Hospital of University of Science and Technology of ...
Lv WF   +7 more
core  

Home - About - Disclaimer - Privacy